Does PATISIRAN Cause Product availability issue? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product availability issue have been filed in association with PATISIRAN (Onpattro). This represents 0.2% of all adverse event reports for PATISIRAN.
6
Reports of Product availability issue with PATISIRAN
0.2%
of all PATISIRAN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product availability issue From PATISIRAN?
Of the 6 reports, 3 (50.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Product availability issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PATISIRAN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does PATISIRAN Cause?
Death (250)
Product dose omission issue (175)
Fatigue (165)
Infusion related reaction (134)
Hospitalisation (127)
Asthenia (108)
Fall (107)
Intentional dose omission (107)
Cardiac failure (95)
Dyspnoea (87)
What Other Drugs Cause Product availability issue?
RUXOLITINIB (2,142)
LISDEXAMFETAMINE DIMESYLATE (1,530)
CERTOLIZUMAB PEGOL (1,381)
VEDOLIZUMAB (636)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610)
METHYLPHENIDATE (444)
SECUKINUMAB (399)
BIMEKIZUMAB-BKZX (364)
LACOSAMIDE (359)
BRIVARACETAM (324)
Which PATISIRAN Alternatives Have Lower Product availability issue Risk?
PATISIRAN vs PAXIL
PATISIRAN vs PAZOPANIB
PATISIRAN vs PEANUT
PATISIRAN vs PEG INTERFERON
PATISIRAN vs PEG-INTERFERON ALFA 2A